The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs ... engaged in anticompetitive practices ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

Ethnic minorities in Bangladesh’s southern hilly region are living in fear after clashes in which four people were killed and dozens wounded, police and witnesses said on Saturday.

© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.